Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.
about
Screening for prostate cancerCurrent status of biomarkers for prostate cancerMolecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancerLimitations and Prospects for Diffusion-Weighted MRI of the ProstateDiagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic reviewScreening Coverage Needed to Reduce Mortality from Prostate Cancer: A Living Systematic ReviewThe Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology AdvancementsTestosterone Replacement Therapy and Prostate Cancer IncidenceActive surveillance and focal therapy for low-intermediate risk prostate cancerMultiparametric prostate magnetic resonance imaging in the evaluation of prostate cancerProstate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based AnalysisObesity and cancer: mechanistic insights from transdisciplinary studiesImmune Infiltration and Prostate CancerWhat is lacking in current decision aids on cancer screening?Opportunities and challenges for the use of large-scale surveys in public health research: a comparison of the assessment of cancer screening behaviorsA conceptual model of the multiple stages of communication necessary to support patient-centered careCancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screeningProstate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Established relevance and emerging rolesCancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screeningValidation of proposed prostate cancer biomarkers with gene expression data: a long road to travelScreening guidelines for non-AIDS defining cancers in HIV-infected individualsThe role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision makingCancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screeningBiomarkers in prostate cancer: what's new?Health literacy and cancer screening: a systematic reviewAnnual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort.The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research.The Role of Personalised Choice in Decision Support: A Randomized Controlled Trial of an Online Decision Aid for Prostate Cancer Screening.Prostate cancer screening in Brazil: should it be done or not?The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistanceHow Precisely Can Prostate Cancer Be Managed?Prostate cancer in Brazil and Latin America: epidemiology and screeningCurrent role of multiparametric magnetic resonance imaging in the management of prostate cancerImpact of Age and Comorbidity on Cervical and Breast Cancer Literacy of African Americans, Latina, and Arab WomenProstate-specific antigen and perfluoroalkyl acids in the C8 health study populationVariable metastatic potentials correlate with differential plectin and vimentin expression in syngeneic androgen independent prostate cancer cellsComparative Metabolomic and Lipidomic Analysis of Phenotype Stratified Prostate CellsA national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancerThe effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA.
P2860
Q24201690-14F45001-C5F3-4CA0-B493-E27B90BEF650Q24600574-43F8FA4B-5C06-48AF-A43C-A9B937C986FFQ26739708-5B6D5D30-6A86-459F-BF26-03D92860E0FAQ26744802-A3C61E9A-6AF9-4586-AFE9-22920AC95291Q26748872-0EC16DFE-309E-4A8D-829A-8858EA5DC9C7Q26748873-5812C6A7-E2A2-4CAC-8989-75B91A50A786Q26750672-05EFFB32-E3E4-4837-A510-993598799D16Q26771774-63D3424F-1336-4B8C-8D49-18598BD6C97FQ26773641-30E1FDC3-7F17-4470-9C5F-8A84F48F5AEFQ26776478-704D2087-A7A2-4B8F-8D2C-B7331F42D0ECQ26781093-5C56C05F-F3BC-4906-980C-1181E385394AQ26786829-02AFDE6B-DF49-4494-BFF1-FF4075A15C31Q26798412-5590BCC9-6ED9-4953-B28C-9CCF5E4CD02BQ26822925-6B8A7FD6-54C4-4C50-943F-D6B8158FA6E2Q26858959-C09F8EB5-42EE-4A4D-BDB7-F3A5A764D523Q26861619-6941F81E-8CA6-4A6A-A8F1-084CD0C7BE9EQ26864419-7C7F2A8E-2F5E-4F24-BE71-57A22FB53358Q26865810-1F36F08A-D896-4B3E-BC5E-5DFAB4447AF9Q27001043-FBAA0157-3027-40C3-913A-81AFFD10E189Q27001399-41E2AB7F-1E76-4D99-8D46-F08ACF7121B5Q27021899-A3593F5F-A2CA-4F00-A1B6-443335137545Q27025062-70A19B96-1FFF-4F3F-85F1-E3B8D4A1D10FQ27025805-23CB2C2E-1C4C-4EA5-AFDE-7007D8FDCAD8Q27026210-5A7088A1-B1B0-42EB-B220-64900F850300Q27026793-76E187E5-8137-4C8C-BC94-A4906608EE77Q27300459-51DB6EFE-28F1-42FC-9831-BD55C2E79D86Q27308897-8553060C-51DD-45D4-90EF-C4B162111EB4Q27311513-9C829AAF-DA09-486C-AB52-2404EC8DAC5AQ27314872-4B9BE658-F0E9-47AD-9612-48B1F602FF56Q28068688-6B86BD9E-F7AA-4C7B-BB84-AB5ADDEC57A7Q28076745-0E900EBA-E9ED-4F7F-9364-E9700A0815A6Q28078942-95D35862-89B5-42C3-B178-E0DA549CE653Q28079012-633831DE-E6BB-4B2B-882E-8A2EACF86ED4Q28082035-ADB0A70B-ED80-4DC2-9E3E-82E30F7C0620Q28082544-5AB0680F-7FF2-4893-A2EF-53E048058B9FQ28384774-1A2C7675-F8A2-485E-8E41-B24BD977646EQ28533234-0E85146B-5E1F-4FB6-A075-9E59FCE9E861Q28547040-47D9CE78-5B74-4AF9-B8CC-A818C4A48DF7Q28652628-4801403C-52D3-4F05-BF6D-3DF442B0C13DQ30239973-3AFB850C-2BA4-4570-A8B3-AC87728AB0BB
P2860
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Screening for prostate cancer: ...... orce recommendation statement.
@ast
Screening for prostate cancer: ...... orce recommendation statement.
@en
Screening for prostate cancer: ...... orce recommendation statement.
@nl
type
label
Screening for prostate cancer: ...... orce recommendation statement.
@ast
Screening for prostate cancer: ...... orce recommendation statement.
@en
Screening for prostate cancer: ...... orce recommendation statement.
@nl
prefLabel
Screening for prostate cancer: ...... orce recommendation statement.
@ast
Screening for prostate cancer: ...... orce recommendation statement.
@en
Screening for prostate cancer: ...... orce recommendation statement.
@nl
P1476
Screening for prostate cancer: ...... orce recommendation statement.
@en
P2093
U.S. Preventive Services Task Force
Virginia A Moyer
P304
P356
10.7326/0003-4819-157-2-201207170-00459
P407
P577
2012-07-01T00:00:00Z